AKT1 and neurofibromatosis: Abnormal activation of the PI3K-Akt signaling pathway has been reported in the literature to be the molecular basis of neurofibromatosis tumorigenesis, and inhibiting this pathway is a potential therapeutic strategy [29, 38].